Skeletal muscle oxidative capacity in patients with cystic fibrosis

Experimental Physiology

Volumn 100, Issue 5, 2015, Pages 545-552

  Erickson, Melissa L ^a   Seigler, Nichole ^b   Mckie, Kathleen T ^b   Mccully, Kevin K ^a   Harris, Ryan A ^b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AEROBIC METABOLISM; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; ELECTROSTIMULATION; EXERCISE TEST; FAT FREE MASS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; NEAR INFRARED SPECTROSCOPY; OXYGEN CONSUMPTION; SKELETAL MUSCLE; SKELETAL MUSCLE OXIDATIVE CAPACITY; VASTUS LATERALIS MUSCLE; AGE; EXERCISE; EXERCISE TOLERANCE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CYSTIC FIBROSIS; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; YOUNG ADULT;

EID: 84929659748     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085037     Document Type: Article

References (25)

1. ACSM (2005). ACSM's Guidelines for Exercise Testing and Prescription, vol. 6. Lippincott Williams and Wilkins, New York.
2. American Thoracic Society (1995). Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152, 1107-1136.
3. Brizendine JT, Ryan TE, Larson RD & McCully KK (2013). Skeletal muscle metabolism in endurance athletes with near-infrared spectroscopy. Med Sci Sports Exerc 45, 869-875.
4. Erickson ML, Ryan TE, Young HJ & McCully KK (2013). Near-infrared assessments of skeletal muscle oxidative capacity in persons with spinal cord injury. Eur J Appl Physiol 113, 2275-2283.
5. Fiedler MA, Nemecz ZK & Shull GE (1992). Cloning and sequence analysis of rat cystic fibrosis transmembrane conductance regulator. Am J Physiol Lung Cell Mol Physiol 262, L779-L784.
6. Godfrey S (1974). Exercise Testing in Children. W.B. Saunders Company Ltd, London.
7. Gulmans VA, deMeer K, Brackel HJ & Helders PJ (1997). Maximal work capacity in relation to nutritional status in children with cystic fibrosis. Eur Respir J 10, 2014-2017.
8. Hamaoka T, McCully KK, Niwayama M & Chance B (2011). The use of muscle near-infrared spectroscopy in sport, health and medical sciences: recent developments. Philos Transact A Math Phys Eng Sci 369, 4591-4604.
9. Lamhonwah AM, Bear CE, Huan LJ, Kim Chiaw P, Ackerley CA & Tein I (2010). Cystic fibrosis transmembrane conductance regulator in human muscle: dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol 67, 802-808.
10. Lutjemeier BJ, Ferreira LF, Poole DC, Townsend D & Barstow TJ (2008). Muscle microvascular hemoglobin concentration and oxygenation within the contraction-relaxation cycle. Respir Physiol Neurobiol 160, 131-138.
11. McCully KK, Mulcahy TK, Ryan TE & Zhao Q (2011). Skeletal muscle metabolism in individuals with spinal cord injury. J Appl Physiol 111, 143-148.
12. McCully KK, Smith S, Rajaei S, Leigh JS Jr & Natelson BH (2003). Blood flow and muscle metabolism in chronic fatigue syndrome. Clin Sci (Lond) 104, 641-647.
13. Nixon PA, Orenstein DM, Kelsey SF & Doershuk CF (1992). The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 327, 1785-1788.
14. Pianosi P, LeBlanc J & Almudevar A (2005). Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 60, 50-54.
15. Ryan TE, Erickson ML, Brizendine JT, Young HJ & McCully KK (2012). Noninvasive evaluation of skeletal muscle mitochondrial capacity with near-infrared spectroscopy: correcting for blood volume changes. J Appl Physiol 113, 175-183.
16. Ryan TE, Erickson ML, Verma A, Chavez J, Rivner MH & McCully KK (2014). Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis. Muscle Nerve 50, 767-774.
17. Ryan TE, Southern WM, Reynolds MA & McCully KK (2013). A cross-validation of near-infrared spectroscopy measurements of skeletal muscle oxidative capacity with phosphorus magnetic resonance spectroscopy. J Appl Physiol 115, 1757-1766.
18. Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, Tullis E, Lands LC, Coates AL, Corey M & Ratjen F (2014). Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. Eur Respir J 43, 817-823.
19. Selvadurai HC, Allen J, Sachinwalla T, Macauley J, Blimkie CJ & Van Asperen PP (2003). Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med 168, 1476-1480.
20. Shapiro BL (1989). Evidence for a mitochondrial lesion in cystic fibrosis. Life Sci 44, 1327-1334.
21. Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, Gosselink R, Decramer M & Dupont L (2009). Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 33, 99-106.
22. Walter G, Vandenborne K, McCully KK & Leigh JS (1997). Noninvasive measurement of phosphocreatine recovery kinetics in single human muscles. Am J Physiol Cell Physiol 272, C525-C534.
23. Wells GD, Wilkes DL, Schneiderman JE, Rayner T, Elmi M, Selvadurai H, Dell SD, Noseworthy MD, Ratjen F, Tein I & Coates AL (2011). Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatr Res 69, 40-45.
24. Williams CA, Saynor ZL, Tomlinson OW & Barker AR (2014). Cystic fibrosis and physiological responses to exercise. Expert Rev Respir Med 8, 751-762.
25. Wolf M, Ferrari M & Quaresima V (2007). Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications. J Biomed Opt 12, 062104.